tirzepatide ruling january 2025 Leads Pharma Growth in with $11.4B in Sales Concerns Surrounding Compounded GLP-1s Mount

GLP-1s still account for a relatively small share of the total number of Medicaid prescriptions, accounting for about 1% of all Medicaid prescriptions in 2024 (up from about 0% in 2019)

These can harm muscle cells and lead to oxidative stress

Skeletal effects of growth hormone and insulin-like growth factor-I therapy

During initial treatment for diagnosed deficiency, providers typically administer injections daily or every other day for one to two weeks

Semaglutide, Ozempic, was approved longer than that for type 2 diabetics, helping with glucose control and helping with glucose utilization

The difference is approximately 8 percentage points, which translates to roughly 20 additional pounds lost for a 250-pound individual